OBJECTIVES: To determine the relationship between apo (a) size and Lp (a) concentration
in healthy Ivorian subjects. METHODS: Serum Lp (a) was measured by …

Cardiovascular risk is associated with high lipoprotein (a)(Lp (a)) concentrations and low
molecular weight apolipoprotein (a)(apo (a)) isoforms. We studied the relationship between …

Plasma lipoprotein (a)[Lp (a)] levels are believed to be controlled predominantly by the
apolipoprotein (a)[APO (a)] gene, which encodes the apo (a) glycoprotein, a key constituent …

Summary Apolipoprotein (a)[apo (a)] exhibits a genetic size polymorphism explaining about
40% of the variability in lipoprotein (a)[Lp (a)] concentration in Tyroleans. Lp (a) …

BACKGROUND: Lp (a) is a proatherogenic lipoprotein that may also be prothrombotic. Apo
(a) size isoforms have differential effects on fibrinolysis. Whereas Lp (a) concentrations have …

The plasma lipoprotein (a)[Lp (a)] distribution in caucasians is heavily skewed to the right,
with evidence of bimodality. As there is a well‐described inverse relationship between …

Plasma Lp [a] levels and apo [a] isoform distribution among lipoproteins isolated by density
gradient ultracentrifugation were studied in subjects with one-band or two-band apo [a] …

Lipoprotein (a)[Lp (a)] is an LDL-like particle whose apo B100 is disulfide-linked to an
apolipoprotein A [apo (a)]. Apo (a) is a glycoprotein containing 23% carbohydrate by weight …

The cynomolgus macaque was used as a model to study lipoprotein (a)(Lp (a)). Antibodies
to Lp (a) were used in Ouchterlony and Western blot analysis to show that cynomolgus …

It is well recognized that blood lipoprotein A [Lp (a)] levels constitute an important risk factor
for atherosclerotic vascular disease. In some populations, mainly Caucasian, Lp (a) levels …